COVID-19 in people living with human immunodeficiency virus: a case series of 33 patientsGeorg Härter, Christian Hoffmann, Christoph D. Spinner et al.|Infection|2020Cited by 246
HIV-Related Neuropathology, 1985 to 1999: Rising Prevalence of HIV Encephalopathy in the Era of Highly Active Antiretroviral TherapyJutta K. Neuenburg, W. Schlote, H.-R. Brodt et al.|JAIDS Journal of Acquired Immune Deficiency Syndromes|2002Cited by 220
Discontinuation of Secondary Prophylaxis against<i>Pneumocystis carinii</i>Pneumonia in Patients with HIV Infection Who Have a Response to Antiretroviral TherapyBruno Ledergerber, Jens Lundgren, Amanda Mocroft et al.|New England Journal of Medicine|2001Cited by 168
Safe Interruption of Maintenance Therapy against Previous Infection with Four Common HIV-Associated Opportunistic Pathogens during Potent Antiretroviral TherapyOle Kirk, Peter Reiss, Caterina Uberti‐Foppa et al.|Annals of Internal Medicine|2002Cited by 136
Prognostic Value of Vitamin D Level for All-cause Mortality, and Association With Inflammatory Markers, in HIV-infected PersonsLeah Shepherd, J.C. Souberbielle, J.-P. Bastard et al.|The Journal of Infectious Diseases|2014Cited by 54